Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-04-17

FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for EZALLOR SPRINKLE (rosuvastatin), updating the product label as part of a supplemental submission by Sun Pharmaceutic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZALLOR SPRINKLE (ROSUVASTATIN)

Snippet

SUPPL AP for EZALLOR SPRINKLE (ROSUVASTATIN)